58 related articles for article (PubMed ID: 7752081)
1. alpha N-acetyl-beta-endorphin-(1-31) disrupts the diminishing effect of mastoparan on opioid- and clonidine-evoked supraspinal antinociception in mice.
Sánchez-Blázquez P; Garzón J
J Pharmacol Exp Ther; 1995 May; 273(2):787-92. PubMed ID: 7752081
[TBL] [Abstract][Full Text] [Related]
2. N-acetyl beta-endorphin-(1-31) and substance P regulate the supraspinal antinociception mediated by mu opioid and alpha-2 adrenoceptors but not by delta opioid receptors in the mouse.
Sánchez-Blázquez P; Garzón J
J Pharmacol Exp Ther; 1993 May; 265(2):835-43. PubMed ID: 7684446
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
[TBL] [Abstract][Full Text] [Related]
4. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
5. In vivo injection of antisense oligodeoxynucleotides to G alpha subunits and supraspinal analgesia evoked by mu and delta opioid agonists.
Sánchez-Blázquez P; García-España A; Garzón J
J Pharmacol Exp Ther; 1995 Dec; 275(3):1590-6. PubMed ID: 8531133
[TBL] [Abstract][Full Text] [Related]
6. Further characterization of alpha N-acetyl beta-endorphin-(1-31) regulatory activity, I: Effect on opioid- and alpha 2-mediated supraspinal antinociception in mice.
Sánchez-Blázquez P; Garzón J
Life Sci; 1992; 50(26):2083-97. PubMed ID: 1318989
[TBL] [Abstract][Full Text] [Related]
7. delta Opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception.
Sánchez-Blázquez P; Garzón J
J Pharmacol Exp Ther; 1998 May; 285(2):820-7. PubMed ID: 9580632
[TBL] [Abstract][Full Text] [Related]
8. Opioids binding mu and delta receptors exhibit diverse efficacy in the activation of Gi2 and G(x/z) transducer proteins in mouse periaqueductal gray matter.
Garzón J; García-España A; Sánchez-Blázquez P
J Pharmacol Exp Ther; 1997 Apr; 281(1):549-57. PubMed ID: 9103543
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive activity of [beta-methyl-2', 6'-dimethyltyrosine(1)]-substituted cyclic [D-Pen(2), D-Pen(5)]Enkephalin and [D-Ala(2),Asp(4)]Deltorphin analogs.
Bilsky EJ; Qian X; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 2000 Apr; 293(1):151-8. PubMed ID: 10734164
[TBL] [Abstract][Full Text] [Related]
11. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1993 Sep; 266(3):1430-8. PubMed ID: 8103794
[TBL] [Abstract][Full Text] [Related]
12. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
[TBL] [Abstract][Full Text] [Related]
13. Effects of ginsenosides injected intrathecally or intracerebroventricularly on antinociception induced by beta -endorphin administered intracerebroventricularly in the mouse.
Suh HW; Song DK; Huh SO; Kim YH
Neuropeptides; 1999 Apr; 33(2):101-6. PubMed ID: 10657478
[TBL] [Abstract][Full Text] [Related]
14. Supraspinal delta- and mu-opioid receptors mediate gastric mucosal protection in the rat.
Gyires K; Rónai AZ
J Pharmacol Exp Ther; 2001 Jun; 297(3):1010-5. PubMed ID: 11356923
[TBL] [Abstract][Full Text] [Related]
15. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
16. Involvement of endogenous opioid peptides in the antinociception induced by the novel dermorphin tetrapeptide analog amidino-TAPA.
Mizoguchi H; Watanabe C; Watanabe H; Moriyama K; Sato B; Ohwada K; Yonezawa A; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Apr; 560(2-3):150-9. PubMed ID: 17307162
[TBL] [Abstract][Full Text] [Related]
17. SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors.
Williams CL; Rosenfeld GC; Dafny N; Fang SN; Hruby VJ; Bowden G; Cullinan CA; Burks TF
J Pharmacol Exp Ther; 1994 May; 269(2):750-5. PubMed ID: 8182541
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of serine/threonine protein phosphatases antagonize the antinociception induced by agonists of alpha 2 adrenoceptors and GABAB but not kappa-opioid receptors in the tail flick test in mice.
Moncada A; Cendán CM; Baeyens JM; Del Pozo E
Pain; 2005 Mar; 114(1-2):212-20. PubMed ID: 15733647
[TBL] [Abstract][Full Text] [Related]
19. Differential modulation by baclofen on antinociception induced by morphine and beta-endorphin administered intracerebroventricularly in the formalin test.
Chung KM; Kim YH; Song DK; Huh SO; Suh HW
Neuropeptides; 1999 Dec; 33(6):534-41. PubMed ID: 10657537
[TBL] [Abstract][Full Text] [Related]
20. Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity.
McLaughlin JP; Hill KP; Jiang Q; Sebastian A; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1999 Apr; 289(1):304-11. PubMed ID: 10087018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]